Showing results (201-210 of 232) with videos related to

Sort By:
Pageof 24
Annals of the Rheumatic Diseases|August 17, 2004
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosusI E A Hoffman, I Peene, L Meheus, et al.
Journal of Clinical Microbiology|December 1, 1987
Collaborative clinical laboratory evaluation of an individual MIC strip systemH D Isenberg, R F D'Amato, G A McKinley, et al.
Annals of the Rheumatic Diseases|October 22, 2008
Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosusI E A Hoffman, B R Lauwerys, F De Keyser, et al.
Experimental Physiology|April 18, 2018
Neuroprotection by post-stroke administration of an oral formulation of angiotensin-(1-7) in ischaemic strokeDouglas M Bennion, Chad H Jones, Lauren L Donnangelo, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2007
Lung cancer in systemic lupus erythematosusJ Bin, S Bernatsky, C Gordon, et al.
Plos One|July 4, 2017
Post-stroke angiotensin II type 2 receptor activation provides long-term neuroprotection in aged ratsDouglas M Bennion, Jacob D Isenberg, Allison T Harmel, et al.
Annals of the Rheumatic Diseases|January 13, 2001
Autoantibody profiles in the sera of European patients with myositisR Brouwer, G J Hengstman, W Vree Egberts, et al.
Arthritis and Rheumatism|March 1, 1996
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosusD Gladman, E Ginzler, C Goldsmith, et al.
Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.
Pageof 24